Skip to main content
. 2022 Jun 22;13(13):2060–2077. doi: 10.1021/acschemneuro.2c00325

Table 1. Notum Inhibition for Fragment Hits 1–59.

graphic file with name cn2c00325_0013.jpg

graphic file with name cn2c00325_0014.jpg

graphic file with name cn2c00325_0015.jpg

graphic file with name cn2c00325_0016.jpg

graphic file with name cn2c00325_0017.jpg

graphic file with name cn2c00325_0018.jpg

a

Fragment number as annotated in the DSPL.

b

Coordinates for these 59 X-ray structures have been published in the PDB.

c

IC50 values are mean ± s.d. of N = 2–4 experiments quoted to 2 s.f. unless stated otherwise. Differences of <2-fold should not be considered as significant. Inhibitors with an IC50 > 1000 μM showed 20–45% inhibition @ 1 mM.

d

MW and clogP calculated with ChemDraw Professional 16.0.1.4.

e

Ligand efficiency, LE = 1.4(−pIC50)/HAC; lipophilic ligand efficiency, LLE = pIC50 – clogP.

f

Compound showed a variable response upon retesting, IC50 > 100 μM.

g

Compound illicited a variable, supramaximal response in fluoresence. Fragment was deselected.

h

ND, not determined. Fragment was deselected.